Journal of Infectious Diseases and Diagnosis

Asian Healthcare Foundation, AIG Hospitals, Gachibowli, Hyderabad, India

Publications

• Research Article   
  Methylene Blue in Treatment of Severe COVID-19 Patients: A Large Cohort Study
  Author(s): Bhanu Prakash Reddy Attunuru*, Madhusudhan Reddy Lingala, Podduturi Naveen Chander Reddy, Anand V Kulkarni, Sasikala Mitnala and Duvvur Nageshwar Reddy
  
  Background and objectives: As there are limited treatment options in treatment severe COVID-19 disease we aim to evaluate the role of methylene blue in management of severe COVID-19 disease. The primary objective was to assess the survival benefit of methylene blue in severe COVID-19 disease. The secondary objective was to compare the duration of hospital stay, the requirement of invasive mechanical ventilation, the development of thrombotic complications and the change in inflammatory markers at discharge/death among the two groups. (SMT group and MB group). Materials and methods: This is a single-center retrospective observational study of 362 patients admitted with severe COVID-19 disease from July 2020 to February 2021 in a tertiary care hospital during first wave of COVID-19 in India. 254 patients received MB at a dos.. View more»
  

  DOI: 10.35248/2576-389X.24.09.298

  Abstract HTML PDF